MyMenopauseRx, MD

MyMenopauseRx is an OB/GYN-led telehealth platform dedicated exclusively to menopause and perimenopause care, founded and clinically directed by Dr. Barbra Hanna, a board-certified OB/GYN and Menopause Society Certified Practitioner. The platform was built on a straightforward clinical philosophy: menopause is a medical event that deserves physician-level attention and evidence-based treatment, and the current shortage of trained menopause specialists means that most women either go untreated or receive generic advice from providers who have not kept pace with the evolving evidence on hormone therapy safety and efficacy. Dr. Hanna's clinical background shapes the platform's approach at every level. MyMenopauseRx operates on a proprietary end-to-end electronic medical record system designed for the specific documentation and follow-up needs of menopause management, and all care is delivered through Zoom consultations that prioritize the depth of a specialist visit over the throughput of a high-volume telehealth platform. The intake process includes a comprehensive women's health medical assessment that covers hormonal symptoms, cardiovascular risk factors, bone health history, mental health status, and prior treatment history — providing clinicians with the context needed to create an individualized care plan rather than a protocol-driven prescription. The platform is insurance-covered by Aetna, Blue Cross Blue Shield, Cigna, Humana, United Healthcare, and TriCare, and MyMenopauseRx's staff proactively helps patients understand their out-of-pocket costs before the visit. For self-pay patients, the $99 initial consultation fee is among the most affordable entry points for OB/GYN-level menopause telehealth in the United States. As of 2025, MyMenopauseRx serves patients in 19 states: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Nevada, Ohio, Tennessee, Texas, Utah, Washington, and Wisconsin. The company has expressed plans to expand its state footprint. Prescriptions are FDA-approved and sent to the patient's pharmacy of choice, with no compounded preparations that lack regulatory oversight. For women who want a physician-led, insurance-supported menopause consultation that feels like a specialist visit rather than a product subscription, MyMenopauseRx delivers a clinically grounded experience with one of the most affordable self-pay entry prices in its category. and the current shortage of trained menopause specialists means that most women either go untreated or receive generic advice from providers who have not kept pace with the evolving evidence on hormone therapy safety and efficacy. Dr. Hanna's clinical background shapes the platform's approach at every level. MyMenopauseRx operates on a proprietary end-to-end electronic medical record system designed for the specific documentation and follow-up needs of menopause management, and all care is delivered through Zoom consultations that prioritize the depth of a specialist visit over the throughput of a high-volume telehealth platform. The intake process includes a comprehensive women's health medical assessment that covers hormonal symptoms, cardiovascular risk factors, bone health history, mental health status, and prior treatment history — providing clinicians with the context needed to create an individualized care plan rather than a protocol-driven prescription. The platform is insurance-covered by Aetna, Blue Cross Blue Shield, Cigna, Humana, United Healthcare, and TriCare, and MyMenopauseRx's staff proactively helps patients understand their out-of-pocket costs before the visit. For self-pay patients, the $99 initial consultation fee is among the most affordable entry points for OB/GYN-level menopause telehealth in the United States. As of 2025, MyMenopauseRx serves patients in 19 states: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Nevada, Ohio, Tennessee, Texas, Utah, Washington, and Wisconsin. The company has expressed plans to expand its state footprint. Prescriptions are FDA-approved and sent to the patient's pharmacy of choice, with no compounded preparations that lack regulatory oversight. For women who want a physician-led, insurance-supported menopause consultation that feels like a specialist visit rather than a product subscription, MyMenopauseRx delivers a clinically grounded experience with one of the most affordable self-pay entry prices in its category.